Orange Prevention Treatment Integrated Medical Assistance – Trademark Portfolio
Entity Type: 99
Orange Prevention Treatment Integrated Medical Assistance holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CALOPTIMA. The owner is based in Orange, CA.
1120 West La Veta Avenue
Orange, CA 92668
Showing of trademarks Trademarks
Trademark Classifications
Orange Prevention Treatment Integrated Medical Assistance's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Orange Prevention Treatment Integrated Medical Assistance have?
Orange Prevention Treatment Integrated Medical Assistance has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Orange Prevention Treatment Integrated Medical Assistance file in?
Orange Prevention Treatment Integrated Medical Assistance files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Orange Prevention Treatment Integrated Medical Assistance's most well-known trademarks?
Orange Prevention Treatment Integrated Medical Assistance's registered trademark portfolio includes well-known marks such as CALOPTIMA. These are among 1 currently registered trademark in the portfolio.
What is Orange Prevention Treatment Integrated Medical Assistance's trademark registration success rate?
Orange Prevention Treatment Integrated Medical Assistance has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.